MedPath

The Effect of Spirulina Platensis on fasting blood Glucose and Lipid Profile in Type 2 diabetic Patients in Mashhad

Phase 3
Recruiting
Conditions
The Effect of Spirulina Platensis on fasting blood Glucose, Glycosylated Hemoglobin (HbA1c) and Lipid Profile in Type 2 diabetic Patients.
Type 2 diabetes mellitus
Registration Number
IRCT20180418039348N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Type 2 Diabetes Mellitus
Fasting plasma glucoseis equal to or greater than 100 to 125 mg / dl
The OGTT test equal to or greater than 140 to 199 mg / dl
Hb1c: 4.6 to 7.5
Less than 5 years of treatment with anti-diabetes drugs

Exclusion Criteria

Not having diabetes
Pregnancy and lactation
Patients with phenylketonuria
36/5000Patients with autoimmune diseases
Patients with kidney or liver failure
Use of antioxidant supplements and vitamins (especially B vitamin groups)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome is the change in hemoglobin beta-glycosylated (HbA1c) levels. Timepoint: The timing is measured at the beginning of the study and the days 30, 60, and 90 of the study. Method of measurement: Chromatography will be used to measure HbA1c.
Secondary Outcome Measures
NameTimeMethod
?Fasting blood Glucoseand Lipid Profile. Timepoint: The timing is measured at the beginning of the study and the days 30, 60, and 90 of the study. Method of measurement: Blood glucose analysis and use of lipid profile kits.
© Copyright 2025. All Rights Reserved by MedPath